March issue of National Geographic explores how engineered silkworms are spinning one of nature’s most powerful materials at ...

VALIDOGEN GmbH, a leading contract research and development organization specializing in recombinant protein expression, strain engineering, and protein production process development, has announced ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...

BBLG READ THE FULL BBLG RESEARCH REPORT Bone Biologics (NASDAQ:BBLG) is a clinical-stage biotechnology company focused on transforming the multibillion-dollar spine fusion and bone regeneration market ...

Bio-based polyhydroxyalkanoates (PHAs) are considered one of the most promising sustainable alternatives to fossil-derived plastics. Poly[(D-lactate)-co-(R)-3-hydroxybutyrate] (LAHB) is an ...

EpitogenX and Attomarker sign co-development agreement to advance precision immunology diagnostics in multiple diseases ...

Q4 2025 Earnings Call February 26, 2026 8:30 AM ESTCompany ParticipantsLuis Sanay - Vice President of Investor RelationsJohn Jacobs ...

Dr Jitendra Singh, the Minister of State (Independent Charge) for the Ministry of Science and Technology, will visit the Biotechnology Research and Innovation Centre (BRIC) at the Rajiv Gandhi Centre ...

GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...

A discovery made at The University of Queensland using blood-clotting proteins found in Australian snake venoms has been ...

Matthew Downham, CEPI’s director of manufacturing and supply chain networks, tells GEN, “Through this partnership, CEPI and Samsung Biologics will establish a pre-agreed, ready-to-activate ...